Can you provide the upcoming earnings date for PURPLE BIOTECH LTD-ADR?
PURPLE BIOTECH LTD-ADR (PPBT) will report earnings on 2026-05-19.
PURPLE BIOTECH LTD-ADR (PPBT) Forecast, Price Target & Analyst Ratings
NASDAQ:PPBT • US74638P1093
Current stock price
3.99 USD
-0.15 (-3.62%)
At close:
4 USD
+0.01 (+0.25%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PURPLE BIOTECH LTD-ADR (PPBT).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $3.99 to mean target of N/A, Based on 0 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-21 | JonesTrading | Initiate | Buy |
| 2023-05-17 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-09 | Chardan Capital | Reiterate | Buy |
| 2023-02-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-17 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-08 | Chardan Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 19, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 100K | 1M 900.00% | 1M | N/A -100.00% | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | -11.069M -54.14% | -7.872M 28.88% | -6.831M 13.22% | N/A -89.74% | N/A -36.49% | N/A -26.63% | N/A 1.46% | N/A 51.90% | |
| EBIT YoY % growth | -11.073M -54.16% | -7.879M 28.84% | -7.009M 11.04% | N/A -88.27% | N/A -35.81% | N/A -26.12% | N/A 1.47% | N/A 51.49% | |
| Operating Margin | -11,073.00% | -787.90% | -700.90% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A